ABOUT PSI

), can help to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those of these mitotic motors was arrested only every time they had been individually inhibited, lending support to your proposal that a combination drug therapy targeting these motors may be a workable system for overcomin